Ä¿¹Â´ÏƼ

¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÀÚ·á½Ç

ÀÚ·á½Ç

¹øÈ£ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏÀÚ Á¶È¸¼ö
°øÁö Licence in, out , sales related (With Investment, Global) °ü¸®ÀÚ 2024-07-09 236
°øÁö FDA ÄÁ¼³ÆÃ, ¹Ì±¹ ÁøÃâ ½ÃÀåÁ¶»ç, Áö¿ø µå¸³´Ï´Ù. °ü¸®ÀÚ 2023-03-27 221
°øÁö EU Regulatory MDD ¿¡¼­ MDR, IVDR Àüȯ¿¡ µû¸¥ Clinical trialÀ» Æ÷ÇÔÇÑ Áö¿ø¹× Áغñ.. °ü¸®ÀÚ 2023-03-27 181
23 Cell therapy capabilitiy from IIT , pre-clinical and IND stages (CAR-T, CAR-NK,M.. °ü¸®ÀÚ 2026-04-03 68
22 ADC CDMO Introduction (Investment ,registration,etc) °ü¸®ÀÚ 2026-04-03 82
21 Medical related added (AI Smart Wearable Device, digital health care,consulting .. °ü¸®ÀÚ 2026-01-14 84
20 Registration (EU) Reference. °ü¸®ÀÚ 2025-05-26 174
19 Peptide Manufacturing Service °ü¸®ÀÚ 2025-04-04 209
18 Cell culture new material ,BD opportunity °ü¸®ÀÚ 2025-04-04 156
17 Sales right opportunity °ü¸®ÀÚ 2025-04-04 231